(Q34212463)

31 July 2017

1 reference

title

Iminosugars as therapeutic agents: recent advances and promising trends (English)

1 reference

31 July 2017

2

Atsushi Kato

1 reference

31 July 2017

Robert J Nash

1

1 reference

31 July 2017

Chu-Yi Yu

series ordinal

3

1 reference

31 July 2017

George Wj Fleet

series ordinal

4

1 reference

31 July 2017

publication date

1 September 2011

1 reference

Future Medicinal Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1513-1521

1 reference

Polyhydroxylated alkaloids -- natural occurrence and therapeutic applications

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Sugar-mimicking glycosidase inhibitors: bioactivity and application

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Iminosugars past, present and future: medicines for tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Therapeutic applications of iminosugars: current perspectives and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Privileged scaffolds for library design and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Natural products as sources of new drugs over the last 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Synthesis and glycosidase inhibition of the enantiomer of (-)-steviamine, the first example of a new class of indolizidine alkaloid

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Structure and synthesis of nojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

The Alkylated Imino Sugar, n -( n -Nonyl)-Deoxygalactonojirimycin, Reduces the Amount of Hepatitis B Virus Nucleocapsid in Tissue Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Pharmacokinetics and anti‐hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4‐dideoxy‐1,4‐imino‐d‐ arabinitol, in glucagon‐challenged rats and dogs and in diabetic ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Imino sugars are potent agonists of the human glucose sensor SGLT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Biological properties of D- and L-1-deoxyazasugars

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Gem-diamine 1-N-iminosugars as versatile glycomimetics: synthesis, biological activity and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.117

21 January 2018

Identifiers

DOI

10.4155/FMC.11.117

1 reference

31 July 2017

1 reference